Marijuana Stocks

Marijuana Stocks – Industry financials and news (below).

XXII
2.14
+0.03 (+1.42%)
ATTBF
0.03
+0.00 (+9.63%)
ABBV
80.06
-1.09 (-1.34%)
AXIM
1.08
-0.03 (-2.70%)
CNBX
0.32
+0.00 (+0.59%)
CARA
18.05
-0.38 (-2.06%)
CRBP
7.30
+0.03 (+0.41%)
GWPH
183.62
-1.07 (-0.58%)
IGC
1.03
-0.03 (-3.30%)
IMLFF
0.33
-0.00 (-0.25%)
INSY
0.88
+0.06 (+7.12%)
NTEC
5.33
+0.19 (+3.70%)
OWCP
0.03
-0.00 (-10.71%)
RSPI
0.85
0.00 (0.00%)
TRPX
2.50
-0.80 (-24.24%)
ZYNE
13.18
-0.35 (-2.59%)
OPMZ
0.00
0.00 (0.00%)
ACCA
0.04
+0.00 (+1.79%)
ADVT
0.02
-0.00 (-6.55%)
APHA
7.35
+0.94 (+14.66%)
ASBFY
32.16
+0.15 (+0.45%)
ACB
8.31
+0.06 (+0.73%)
ACNNF
0.26
-0.01 (-3.19%)
BLEVF
0.07
+0.01 (+9.03%)
BHHKF
0.38
+0.05 (+16.40%)
CBDS
1.96
+0.01 (+0.59%)
CBIS
0.03
-0.00 (-2.86%)
CGRW
0.51
-0.01 (-2.88%)
TRST
7.67
+0.11 (+1.46%)
CLSH
0.29
+0.01 (+5.38%)
CODI
16.18
-0.23 (-1.40%)
CRON
15.38
+0.01 (+0.07%)
CVSI
4.90
+0.37 (+8.07%)
ETST
0.50
+0.02 (+3.95%)
ELLXF
3.63
-0.02 (-0.55%)
SEED
6.16
+0.06 (+0.98%)
GBHPF
0.05
+0.00 (+5.01%)
GLDFF
0.08
+0.00 (+0.65%)
GRCU
0.00
0.00 (0.00%)
HEMP
0.02
-0.00 (-3.00%)
HMPQ
0.01
-0.00 (-18.75%)
IVITF
0.36
-0.01 (-3.01%)
KAYS
0.07
+0.01 (+17.26%)
KSHB
4.80
+0.16 (+3.45%)
LXRP
0.89
-0.02 (-2.19%)
MGWFF
0.11
-0.01 (-4.35%)
MCIG
0.07
-0.00 (-2.17%)
MJNA
0.07
+0.00 (+1.32%)
LEAF
7.39
-0.11 (-1.47%)
MYDX
0.00
0.00 (0.00%)
NSPDF
0.10
+0.01 (+17.08%)
USMJ
0.00
0.00 (0.00%)
SPLIF
0.16
+0.00 (+2.64%)
OGRMF
8.35
0.00 (0.00%)
PHVAF
0.46
+0.01 (+2.01%)
SMG
88.87
+1.02 (+1.16%)
SPRWF
1.33
+0.02 (+1.62%)
TRTC
0.75
+0.03 (+3.65%)
VAPE
0.00
-0.00 (-7.14%)
VAPE
0.00
-0.00 (-7.14%)
VDQSF
0.06
+0.00 (+0.05%)
VPRB
0.07
0.00 (0.00%)
WDDMF
1.28
+0.03 (+2.40%)
AMMJ
0.33
-0.02 (-6.61%)
ERBB
0.00
0.00 (0.00%)
CANN
1.52
-0.10 (-6.17%)
LEVB
6.08
+0.53 (+9.55%)
MRMD
2.99
+0.02 (+0.74%)
MDCL
3.70
+0.36 (+10.78%)
PNPL
0.55
0.00 (0.00%)
CNAB
0.42
-0.00 (-0.06%)
APPB
1.60
0.00 (0.00%)
CBWTF
0.62
+0.00 (+0.81%)
CPMD
1.51
0.00 (0.00%)
DIGP
0.16
-0.01 (-3.26%)
FRLF
0.15
-0.01 (-7.09%)
TGIFF
0.37
+0.04 (+11.04%)
ITHUF
3.97
+0.05 (+1.15%)
ISOLF
0.93
+0.11 (+13.19%)
JMDA
0.08
-0.05 (-39.26%)
LBUY
0.95
-0.04 (-4.28%)
MNTR
0.37
+0.02 (+5.41%)
NXTTF
0.62
+0.03 (+5.82%)
NTRR
0.01
+0.00 (+18.18%)
PMD
10.51
-0.10 (-0.94%)
PUFXF
0.30
-0.03 (-8.21%)
WDLF
0.14
+0.00 (+0.36%)
TNYBF
0.50
+0.01 (+1.48%)
FTPM
0.00
0.00 (0.00%)
AGTK
0.31
-0.01 (-3.12%)
ACAN
1.35
+0.05 (+3.85%)
CGRA
0.01
+0.00 (+2.20%)
CRXPF
0.19
-0.01 (-5.35%)
DPWW
0.02
-0.00 (-2.62%)
FUTL
0.00
0.00 (0.00%)
GRWC
0.23
+0.00 (+2.21%)
IIPR
87.29
+0.68 (+0.79%)
MJNE
0.56
-0.00 (-0.60%)
MYMMF
0.34
0.00 (0.00%)
PRRE
0.14
0.00 (0.00%)
TURV
0.50
-0.01 (-1.96%)
ZDPY
0.33
+0.03 (+10.00%)
AERO
1.24
+0.05 (+4.20%)
RSSFF
0.03
-0.00 (-8.46%)
BLOZF
0.85
-0.01 (-0.91%)
EDXC
0.35
+0.02 (+5.45%)
FFRMF
0.08
-0.00 (-4.63%)
GBLX
0.15
+0.00 (+1.83%)
GRNH
0.02
+0.00 (+4.34%)
GRSO
0.01
-0.00 (-9.09%)
GRWG
3.30
-0.01 (-0.30%)
PHOT
0.01
-0.00 (-0.62%)
HLSPY
0.54
-0.04 (-7.18%)
6924.T
1,362.00
-5.00 (-0.37%)
MBII
1.65
-0.03 (-1.79%)
MSRT
0.05
-0.00 (-1.82%)
MICWF
0.25
+0.01 (+2.23%)
NUVG
0.04
+0.00 (+2.94%)
SRNA
0.05
+0.00 (+7.99%)
Last updated: Monday 27, May 2019 @ 09:47:06
Symbol Company Last
Price
Change % Chg Volume Market Cap
XXII ASE 22nd Century Group, Inc. 2.14 +0.03 +1.42% 589,130 266,772,416
ATTBF PNK Abattis Bioceuticals Corp. 0.03 +0.00 +9.63% 342,654 15,411,957
ABBV NYQ AbbVie Inc. 80.06 -1.09 -1.34% 3,872,999 118,355,091,456
AXIM PNK AXIM Biotechnologies, Inc. 1.08 -0.03 -2.70% 56,356 66,498,196
CNBX PNK Cannabics Pharmaceuticals Inc. 0.32 +0.00 +0.59% 100,414 42,462,156
CARA NGM Cara Therapeutics, Inc. 18.05 -0.38 -2.06% 1,183,159 717,516,352
CRBP NGM Corbus Pharmaceuticals Holdings, Inc. 7.30 +0.03 +0.41% 1,077,875 470,522,976
GWPH NGM GW Pharmaceuticals plc 183.62 -1.07 -0.58% 316,770 5,640,071,680
IGC ASE India Globalization Capital, Inc. 1.03 -0.03 -3.30% 290,883 40,576,468
IMLFF PNK InMed Pharmaceuticals Inc. 0.33 -0.00 -0.25% 154,474 55,677,048
INSY NGM INSYS Therapeutics, Inc. 0.88 +0.06 +7.12% 965,216 66,809,600
NTEC NCM Intec Pharma Ltd. 5.33 +0.19 +3.70% 316,224 177,475,136
OWCP PNK OWC Pharmaceutical Research Corp. 0.03 -0.00 -10.71% 2,113,705 4,675,525
RSPI PNK RespireRx Pharmaceuticals Inc. 0.85 0.00 0.00% 6 3,291,268
TRPX NCM Therapix Biosciences Ltd. 2.50 -0.80 -24.24% 121,027 10,372,900
ZYNE NGM Zynerba Pharmaceuticals, Inc. 13.18 -0.35 -2.59% 1,696,105 277,768,512
OPMZ PNK 1PM Industries, Inc. 0.00 0.00 0.00% 6,100 426,277
ACCA PNK Acacia Diversified Holdings, Inc. 0.04 +0.00 +1.79% 24,976 972,002
ADVT PNK Advantis Corp. 0.02 -0.00 -6.55% 782,718 13,791,915
APHA NYQ Aphria Inc. 7.35 +0.94 +14.66% 12,820,904 1,851,781,120
ASBFY PNK Associated British Foods plc 32.16 +0.15 +0.45% 13,495 25,575,948,288
ACB NYQ Aurora Cannabis Inc. 8.31 +0.06 +0.73% 7,483,887 8,495,729,152
ACNNF PNK AusCann Group Holdings Ltd 0.26 -0.01 -3.19% 82,587 79,209,320
BLEVF PNK Beleave Inc. 0.07 +0.01 +9.03% 250,436 32,987,150
BHHKF PNK Benchmark Botanics Inc. 0.38 +0.05 +16.40% 2,000 88,301,568
CBDS PNK Cannabis Sativa, Inc. 1.96 +0.01 +0.59% 20,017 43,434,084
CBIS PNK Cannabis Science, Inc. 0.03 -0.00 -2.86% 2,981,668 93,364,352
CGRW PNK CannaGrow Holdings, Inc 0.51 -0.01 -2.88% 21,569 51,143,368
TRST NMS TrustCo Bank Corp NY 7.67 +0.11 +1.46% 69,006 742,627,072
CLSH PNK CLS Holdings USA, Inc. 0.29 +0.01 +5.38% 88,122 36,493,308
CODI NYQ Compass Diversified Holdings LLC 16.18 -0.23 -1.40% 117,542 969,182,016
CRON NGM Cronos Group Inc. 15.38 +0.01 +0.07% 3,621,656 5,144,133,120
CVSI PNK CV Sciences, Inc. 4.90 +0.37 +8.07% 1,685,417 483,418,336
ETST PNK Earth Science Tech, Inc. 0.50 +0.02 +3.95% 18,700 26,080,200
ELLXF PNK Elixinol Global Limited 3.63 -0.02 -0.55% 104,189 450,933,120
SEED NMS Origin Agritech Limited 6.16 +0.06 +0.98% 1,466 17,790,510
GBHPF PNK Global Hemp Group Inc. 0.05 +0.00 +5.01% 16,773 8,730,621
GLDFF PNK Golden Leaf Holdings Ltd. 0.08 +0.00 +0.65% 290,156 46,650,552
GRCU PNK Green Cures & Botanical Distribution Inc. 0.00 0.00 0.00% 1,563,497 1,396,574
HEMP PNK Hemp Inc. 0.02 -0.00 -3.00% 18,858,259 75,858,032
HMPQ PNK HempAmericana, Inc 0.01 -0.00 -18.75% 13,725,065 23,360,976
IVITF PNK Invictus MD Strategies Corp. 0.36 -0.01 -3.01% 96,463 43,764,752
KAYS PNK Kaya Holdings, Inc. 0.07 +0.01 +17.26% 249,369 12,499,055
KSHB PNK KushCo Holdings, Inc. 4.80 +0.16 +3.45% 192,507 423,583,104
LXRP PNK Lexaria Bioscience Corp. 0.89 -0.02 -2.19% 106,459 69,764,520
MGWFF PNK Maple Leaf Green World Inc. 0.11 -0.01 -4.35% 77,650 17,716,050
MCIG PNK mCig, Inc. 0.07 -0.00 -2.17% 474,365 34,895,816
MJNA PNK Medical Marijuana, Inc. 0.07 +0.00 +1.32% 7,100,706 250,628,560
LEAF NYQ Leaf Group Ltd. 7.39 -0.11 -1.47% 35,621 191,060,320
MYDX PNK MyDx, Inc. 0.00 0.00 0.00% 549,185 5,606,496
NSPDF PNK Naturally Splendid Enterprises Ltd. 0.10 +0.01 +17.08% 2,000 10,258,187
USMJ PNK North American Cannabis Holdings, Inc. 0.00 0.00 0.00% 25,448,050 0
SPLIF PNK Nutritional High International Inc. 0.16 +0.00 +2.64% 33,220 51,985,860
OGRMF PNK OrganiGram Holdings Inc. 8.35 0.00 0.00% 2,048,866 1,287,595,136
PHVAF PNK Phivida Holdings Inc. 0.46 +0.01 +2.01% 52,363 27,789,460
SMG NYQ The Scotts Miracle-Gro Company 88.87 +1.02 +1.16% 188,156 4,929,752,576
SPRWF PNK The Supreme Cannabis Company, Inc. 1.33 +0.02 +1.62% 223,505 390,310,496
TRTC PNK Terra Tech Corp. 0.75 +0.03 +3.65% 257,552 77,376,000
VAPE PNK Vape Holdings, Inc. 0.00 -0.00 -7.14% 592,071 1,300,000
VAPE PNK Vape Holdings, Inc. 0.00 -0.00 -7.14% 592,071 1,300,000
VDQSF PNK Vodis Pharmaceuticals Inc. 0.06 +0.00 +0.05% 1,000 3,795,205
VPRB PNK VPR Brands, LP 0.07 0.00 0.00% 221,050 6,283,864
WDDMF PNK WeedMD Inc. 1.28 +0.03 +2.40% 12,428 144,610,560
AMMJ PNK American Cannabis Company, Inc. 0.33 -0.02 -6.61% 93,978 16,941,534
ERBB PNK American Green, Inc. 0.00 0.00 0.00% 66,982,271 8,684,160
CANN PNK General Cannabis Corp 1.52 -0.10 -6.17% 284,349 55,104,256
LEVB ASE Level Brands, Inc. 6.08 +0.53 +9.55% 603,555 61,836,032
MRMD PNK MariMed Inc. 2.99 +0.02 +0.74% 179,488 636,206,912
MDCL PNK Medicine Man Technologies, Inc. 3.70 +0.36 +10.78% 400,714 103,544,872
PNPL PNK Pineapple Express, Inc. 0.55 0.00 0.00% 100 41,724,592
CNAB PNK United Cannabis Corporation 0.42 -0.00 -0.06% 61,120 32,606,768
APPB PNK Applied Biosciences Corp. 1.60 0.00 0.00% 30 21,515,360
CBWTF PNK Auxly Cannabis Group Inc. 0.62 +0.00 +0.81% 370,839 378,751,808
CPMD PNK CannaPharmaRX, Inc. 1.51 0.00 0.00% 8 48,979,868
DIGP PNK DigiPath, Inc. 0.16 -0.01 -3.26% 74,484 7,653,909
FRLF PNK Freedom Leaf, Inc. 0.15 -0.01 -7.09% 379,093 33,474,302
TGIFF PNK 1933 Industries Inc. 0.37 +0.04 +11.04% 2,235,149 101,697,032
ITHUF PNK iAnthus Capital Holdings, Inc. 3.97 +0.05 +1.15% 341,039 671,295,104
ISOLF PNK Isodiol International Inc. 0.93 +0.11 +13.19% 893,368 45,241,676
JMDA PNK Jerrick Media Holdings, Inc. 0.08 -0.05 -39.26% 19,996 12,044,079
LBUY PNK Leafbuyer Technologies, Inc. 0.95 -0.04 -4.28% 63,134 45,049,664
MNTR PNK Mentor Capital, Inc. 0.37 +0.02 +5.41% 7,950 8,561,726
NXTTF PNK Namaste Technologies Inc. 0.62 +0.03 +5.82% 475,426 190,947,600
NTRR PNK Neutra Corp. 0.01 +0.00 +18.18% 5,054,981 289,837
PMD NCM Psychemedics Corporation 10.51 -0.10 -0.94% 12,253 57,881,304
PUFXF PNK AgraFlora Organics International Inc. 0.30 -0.03 -8.21% 906,354 145,587,360
WDLF PNK Social Life Network, Inc. 0.14 +0.00 +0.36% 11,000 17,935,260
TNYBF PNK The Tinley Beverage Company Inc. 0.50 +0.01 +1.48% 16,917 50,453,704
FTPM PNK 420 Property Management, Inc. 0.00 0.00 0.00% 1,500,000 495,128
AGTK PNK Agritek Holdings, Inc. 0.31 -0.01 -3.12% 12,374 2,026,959
ACAN PNK AmeriCann, Inc. 1.35 +0.05 +3.85% 20,042 30,919,860
CGRA PNK CGrowth Capital, Inc. 0.01 +0.00 +2.20% 400,433 3,420,949
CRXPF PNK Crop Infrastructure Corp. 0.19 -0.01 -5.35% 376,483 30,043,560
DPWW PNK Diego Pellicer Worldwide, Inc. 0.02 -0.00 -2.62% 229,405 1,207,802
FUTL PNK FutureLand, Corp. 0.00 0.00 0.00% 470,000 671,625
GRWC PNK Grow Capital, Inc. 0.23 +0.00 +2.21% 170,933 29,573,194
IIPR NYQ Innovative Industrial Properties, Inc. 87.29 +0.68 +0.79% 211,580 855,982,336
MJNE PNK MJ Holdings, Inc. 0.56 -0.00 -0.60% 3,017 45,933,492
MYMMF PNK MYM Nutraceuticals Inc. 0.34 0.00 0.00% 108,980 44,179,600
PRRE PNK Praetorian Property, Inc. 0.14 0.00 0.00% 35 21,645,000
TURV PNK Two Rivers Water & Farming Company 0.50 -0.01 -1.96% 193,218 25,175,100
ZDPY PNK Zoned Properties, Inc. 0.33 +0.03 +10.00% 800 3,927,495
AERO PNK Aerogrow International, Inc. 1.24 +0.05 +4.20% 3,450 42,566,720
RSSFF PNK Affinor Growers Inc. 0.03 -0.00 -8.46% 36,000 4,464,913
BLOZF PNK Cannabix Technologies Inc. 0.85 -0.01 -0.91% 67,838 88,645,088
EDXC PNK CBD Unlimited, Inc. 0.35 +0.02 +5.45% 311,380 105,503,152
FFRMF PNK Future Farm Technologies Inc. 0.08 -0.00 -4.63% 346,441 11,887,982
GBLX PNK GB Sciences, Inc. 0.15 +0.00 +1.83% 234,043 36,281,852
GRNH PNK GreenGro Technologies, Inc. 0.02 +0.00 +4.34% 689,996 7,776,675
GRSO PNK Grow Solutions Holdings, Inc. 0.01 -0.00 -9.09% 6,327,288 1,147,290
GRWG PNK GrowGeneration Corp. 3.30 -0.01 -0.30% 71,339 95,187,176
PHOT PNK GrowLife, Inc. 0.01 -0.00 -0.62% 6,107,553 25,793,484
HLSPY PNK Heliospectra AB (publ) 0.54 -0.04 -7.18% 152 22,048,286
6924.T JPX Iwasaki Electric Co., Ltd. 1,362.00 -5.00 -0.37% 2,900 10,533,912,576
MBII NCM Marrone Bio Innovations, Inc. 1.65 -0.03 -1.79% 54,742 182,696,240
MSRT PNK MassRoots, Inc. 0.05 -0.00 -1.82% 219,187 10,180,350
MICWF PNK Micron Waste Technologies Inc. 0.25 +0.01 +2.23% 24,500 19,915,608
NUVG PNK NuvusGro Corp 0.04 +0.00 +2.94% 10,898 1,949,643
SRNA PNK Surna Inc. 0.05 +0.00 +7.99% 397,186 10,927,536
Last updated: Monday 27, May 2019 @ 09:47:06

Market News - May 27, 2019

Push for legislation allowing banks to serve the cannabis business is gaining momentum

The push for legislation that would allow banks do business with cannabis companies without the risk of federal enforcement action is gaining momentum and credit unions are playing a key role.

Bad Timing Hits Marijuana's Newest ETF

Picking the wrong time to debut has proven difficult for Pure Cannabis.

California Reports Cannabis Sales Tax Revenue: Massive Growth, But Still Below Expectations

California just made public its cannabis excise taxes numbers for the first quarter of 2019. Based on the reported figures, total adult use sales rose by 92 percent year-over-year, from $213 million in the first quarter of 2018 to $409.3 million for the first quarter of 2019. “Most of the growth is attributed to ‘preregulated’ inventory that was sold through in the first quarter of 2018 but not taxed,” Matt Karnes, founder and managing partner of GreenWave Advisors, told Benzinga.

Canadian Government Earmarks $18.5M For Cannabis Research, Education

Blair was the driving force behind the Cannabis Act during this tenure as a Member of Parliament. Among the studies that will be conducted at the university, there’s one focused on cannabinoid hyperemesis syndrome (CHS). “Experiencing Cannabinoid Hyperemesis Syndrome has been challenging physically and mentally," Alice Moon, Director of Communications for Blunt Talks and vocal advocate for CHS awareness told Benzinga.

Cannabis Stock Pick of the Week: Zenabis Global

The cannabis market is expanding so fast that keeping up with all of the different companies jumping into the business and going public is near impossible. At the same time, some of the developments under the radar of the general market provide opportunities for investors willing to take on risk.One suddenly interesting play in the Canadian cannabis sector is Zenabis Global (ZBISF) that was formed via a RTO merger in January. The company is a potential hidden giant in the making.Major PlansZenabis Global definitely talks a big game. The licensed cultivator of medical and recreational cannabis was formed in January via the combination of Bevo Agro, Inc. and Sun Pharm Investments Ltd.The combination provided a propagation business with greenhouses in North America with a large privately held cannabis producer that operates four facilities intended for cannabis cultivation. Zenabis has a stated plan to reach cannabis production capacity of 131,300 kg in Q3 with a total design capacity of 479,300 kg.The company has very lofty goals for a cannabis player that has yet to top 1,000 kg in monthly cultivation. New CEO Andrew Grieve shared the following corporate objectives along with the conditional approval of “ZENA” joining the Toronto Stock Exchange: * Becoming one of the largest licensed producers of medical and adult-use cannabis in Canada and securing competitive positions in a number of international markets. * Achieving industrial scale cultivation of top-quality cannabis at a low cost. * Rolling out a large offering of ultra premium, premium and value cannabis products to the market through our significant distribution networks.The interesting part is that the stock only has a market cap of $250 million despite all of the large-scale plans in the Canadian cannabis sector. The Sun Pharm portion of the business generated Q4 revenues of C$3.8 million primarily from the medical and recreational cannabis market in Canada while the main Bevo greenhouse is being converted to grow cannabis.Another interesting part is that Zenabis under the new leadership of Andrew Grieve has taken on the stance of providing transparent details on monthly cultivation numbers and plans. The existing licensed Zenabis facilities have the following cultivation targets:Source: Zenabis press releaseMajor UplistingThe biggest news for the stock could be the impending uplisting to the TSE. The company announced conditional approval on April 22. Such a move could lead to a listing on a major exchange in the U.S. similar to the big Canadian LPs that obtained outsized market valuations.The company might be better off pursuing business in the U.S. cannabis market, but a move to the TSE will provide substantially more liquidity for the stock and hence a much higher valuation in the short term. The major exchanges don’t allow for listings of companies with a business that is illegal on a federal level such as cannabis in the U.S.The stock is already down substantially from the highs following the news of the RTO merger. The next key catalyst along with the TSE uplisting that would provide major credibility to the new cannabis firm is Q1 earnings on May 30. The report will provide the first financials of the new company along with analyst access to the CEO and new CFO.TakeawayThe key investor takeaway is that Zenabis Global has an incredible plan to turn the greenhouse and growing expertise of Bevo Agro along with the cannabis licenses of Sun Pharm to build a cannabis industry leader.The market hasn’t taken notice of the stock yet. The current valuation near $250 million is not reflective of the potential growth of the company with one of the largest cannabis cultivation plans.To read more on the nitty gritty of what’s going on in the rising cannabis industry, click here. Disclosure: The author has no positions in Zenabis Global stock. More recent articles from Smarter Analyst: * Love or Hate Aurora Cannabis (ACB) Stock, That’s Where the Money Is * Micron's (MU) Tech Roadmap Highlights Flattening Cost Curve, Says Analyst; Reiterates Neutral on the Stock * Time to Cash Out on Cannabis Stock Canopy Growth (CGC) * GW Pharmaceuticals (GWPH) Stock Could Run Much Higher Over Time

Tilray's Portugal sub receives GMP certification for export of dried cannabis

Tilray Inc. said its Portugal-based wholly-owned subsidiary, Tilray Portugal Unipessoal Lda. has received a Good Manufacturing Practices (GMP) certification and a standard manufacturing license, which allows Tilray Portugal to export GMP-certified dried cannabis for medicinal products. "This licensing and certification marks a critical milestone for our growth in Portugal and Europe," said Sascha Mielcarek, managing director of Europe. "We're proud to increase our international export capacity and are looking forward to exporting dried cannabis as active substances from our EU Campus to legal jurisdictions in the EU and other international markets." The stock fell 0.6% in premarket trade. It has tumbled 41.5% over the past three months, while the ETFMG Alternative Harvest ETF has slipped 6.8% and the S&P 500 has gained 2.3%.

Canada Gets World's First Inverse, Leveraged Cannabis ETFs

Already one of the world's largest markets in terms of sheer number of cannabis exchange traded funds, Canada is breaking new ground as the home to the world's first inverse and leveraged marijuana ETFs. ...

The Surprising Way Trump's US-China Trade Dispute Hurts Marijuana Users

Major political disputes often create unpredictable ripples in the world of cannabis. When President Donald Trump caused a government shutdown because legislators wouldn’t fund his border wall, that meant government workers were left without pay or medical services. Like, for example, when the Cato Institute discovered legalizing marijuana would do more to curb illegal drug smuggling than a wall ever could.

Cannabis Stocks Struggle to Find Direction

Why Canopy Growth Is on the Rise Today(Continued from Prior Part)Cannabis sectorThe cannabis sector has been struggling to find direction on May 22, with cannabis stocks trading on a largely mixed note in the first half. During the first half of the

HEXO, CTST, and Other Cannabis Stocks Gain as Tension Eases

Aphria Stock Rises on Cultivation License in Germany(Continued from Prior Part)Cannabis stocks gainToday, the cannabis sector was making positive moves after last week was fraught with pessimism due to trade tensions. HEXO (HEXO) was up 1.3% while

Aurora Cannabis partners with UFC on advancing CBD research

Shares of Aurora Cannabis Inc. rallied 1.5% in premarket trade Tuesday, after the Canada-based cannabis company announced a "multi-year, multi-million dollar" exclusive partnership with UFC to advance research on the relationship between of hemp-derived cannabidiol (CBD) products and athlete wellness and recovery. The research will be conducted at the mixed martial arts organization's performance institute in Las Vegas, with clinical studies to focus on pain management, inflammation, injury/exercise recovery and mental well being. "This global partnership places focus squarely on the health and well-being of UFC's talented and highly trained athletes," said Aurora Chief Executive Terry Booth. "The Aurora-UFC research partnership creates a global platform to launch targeted educational and awareness campaigns, while creating numerous opportunities to accelerate our global CBD business." Aurora's stock has soared 71.2% year to date through Monday, while the ETFMG Alternative Harvest ETF has climbed 33.3% and the S&P 500 has gained 13.3%.

New Report Says US Cannabis Market Could Hit $22.7B By 2023, New York And Massachusetts To Emerge As Leaders

The estimates in the Brightfield Group report imply a compound annual growth rate (CAGR) of 20 percent over the next four years. The recreational market is expected to lead the charge, at least in 2019, delivering 33 percent growth, driven by a variety of factors including the stabilization of the market in California and new adult-use markets coming online. Brightfield Group’s estimates assume the number of active adult-use states (meaning those currently selling products, versus those with laws in place but no real sales) will surge from seven in 2019 to 16 by 2023.

Cannabis: Seven Avoidable Investment Mistakes

While this provides a rare wealth-creation opportunity, the road to maturity for this emerging market is also unusually impacted by legislation, taxation, regulation and margin normalization across every investable sector. Cannabis is poised to impact every vertical in the economy, following a path similar in some ways to the one technology took when it went from being a sector to becoming an undeniable part of every sector. Lessons from previous cycles can serve as a useful guide towards better decisions for the informed investor.

From High To Health: A New Cannabis Paradigm

The words, "Dad, you said the 'F' word!" were delivered in an authoritarian manner from the back seat. In that instant, I had an "F word" flashback. One night's vivid memory: an Ozzie and Harriet, nuclear family kitchen scene: white Formica table, yellow pleather chairs, table set perfectly.

Should You Buy Canopy Growth Stock? 3 Pros, 3 Cons

Canopy Growth (NYSE:CGC) just isn't getting as high as it used to. But CGC stock isn't alone. The marijuana stocks have lost a lot of their buzz lately. The sector fund, the Alternative Harvest ETF (NYSEARCA:MJ) has dropped roughly 15% from its recent highs in March. On top of that, its current $33 share price is well off the $45 level where marijuana stocks peaked just before Canada's legalization went into effect last fall.Source: Shutterstock CGC stock has fared better than many of its rivals. But its stock hasn't been able to hit new highs in awhile either, as the $50 price level has been key resistance. With the company making major acquisitions ahead of earnings and short sellers betting the farm against the stock, expect CGC stock to make big moves in coming weeks. CGC Stock ConsAcreage Deal Isn't A Standard Acquisition: Canopy Growth recently announced a deal to purchase Acreage Holdings (OTCMKTS:ACRGF). This deal is a rather odd one for a number of reasons.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Stocks to Buy that Lost 10% Last Week To start with, the deal is contingent on the U.S. legalizing marijuana federally. The deal is structured with a 90 month (7 and a half years) time limit. It will be terminated if federal legalization doesn't occur within that time frame. As it is, Canopy is taking some risk. That is because it is paying a not insubstantial $300 million upfront for the deal, along with far more than that in CGC stock once the deal closes.Given that the deal could take ages to close, Canopy could be giving up a lot of value with its shares. That will depend on where the share price is in coming years. Additionally, there's a risk that Acreage shareholders will oppose the deal, as Canopy is offering a rather modest premium for the acquisition.CGC Stock Hitting Major Resistance: From a technical analysis standpoint, Canopy Growth stock is starting to get itself into trouble. For the better part of a year now, CGC stock has stopped dead in its tracks every time it reaches near the $50 mark.Canopy Growth stock first hit the $50 level last fall. It spent the better part of September trading around that figure. Shares subsequently dumped all the way to $25. But CGC stock bounced back, hitting $50 again in January. That rally petered out, and shares declined 20%. In April, CGC stock again briefly reclaimed the $50 level but has already dropped back almost 15% since that point. $50 is turning into a major resistance point for Canopy stock. Going forward, bulls need to get the stock to close above $50 before serious trading momentum can get going again.Valuation Is Still Strained: Canopy Growth -- and most of its publicly traded rivals that focus on recreational marijuana -- have yet to deliver compelling earnings. In fact, for many firms, free cash burn has actually gotten worse. Companies keep ramping up their growth expenses without enough revenues to offset those costs just yet.Already, we're starting to see issues on the revenue side. The price of recreational marijuana keeps dropping, sales volumes are flattening out, and producers seemingly have a huge oversupply of marijuana on hand. Canopy still has time to find its way to profitability thanks to the Constellation (NYSE:STZ) cash infusion. But it's burning through that money awfully quickly.Not only are the operations losing money, but it keeps making big purchases like Acreage and the German deal announced earlier this month for close to another $250 million. CGC Stock ProsDeals Could Pay Off Big: While these latest deals certainly come with risk, they could pay off for Canopy. The German deal, acquiring the C3 Cannabinoid Compound Company looks interesting in particular. C3 has developed various products to treat pain in cancer patients, among other uses.C3 already has a healthy $30 million or so in annual revenues. This suggests that Canopy only paid about 8x annual sales for the deal. Compared to many of the deals going off in the hyped-up marijuana space, that's a defensible valuation. $30 million in (presumably fast-growing) annual revenues will be enough to move the needle for Canopy Growth more generally as well.CGC Stock Holding Up Better: Canopy Growth stock is having a mighty difficult time trying to break out above the $50/share level. But at least it is still somewhere near its recent trading highs.Other pot stocks have gotten crushed lately. Cronos (NASDAQ:CRON), Aurora (NYSE:ACB) and Aphria (NASDAQ:APHA) have all fared worse than Canopy. There's a lot of value in being the strongest performing major stock within the industry. When marijuana stocks rally as a group, it may be enough to power CGC stock past that $50 barrier and onward to new all-time highs.Short Squeeze Potential: As I sometimes warn, you generally shouldn't base a whole investment thesis on the potential for a short squeeze. That said, if you are already considering taking a long position, high short interest could be the thing that causes the stock to run in the short term.Canopy Growth's stock has an incredible 75 million shares shorted (on its U.S. listing). That makes up 35% of the float. This is among the highest short ratios you'll find out there for a large widely-traded stock today. Clearly short sellers are betting on Canopy's next earnings report being a dud. That would be in line with what other pot players have produced recently. But if they're wrong, the stock could make a violent move higher. CGC Stock VerdictI don't see this as a great time to get into CGC stock. The firm has outperformed its other marijuana peers recently. But a poor earnings report could drive CGC stock right back down with the rest of the pack. Given how strong the $50 resistance level has been, bears are logically pressing their bets here. * 3 Reasons Not to Sell Canopy Growth Stock If Canopy Growth can deliver a strong earnings report, that would change everything. But until investors see a clearer path to profits and a more stable business trajectory, odds will continue to favor the bears. I'd stick to the sidelines in Canopy stock for the time being.At the time of this writing, Ian Bezek held no positions in any of the aformentioned securities. You can reach him on Twitter at @irbezek. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 10 Retirement Stocks That Won't Wilt in a Bear Market * 5 Consumer Stocks Ready to Push Higher * 3 of the Best ETFs to Buy for a Play on Gold Stocks Compare Brokers The post Should You Buy Canopy Growth Stock? 3 Pros, 3 Cons appeared first on InvestorPlace.

RegTalk: DOJ Issues Guidance On A Well Designed And Effective Corporate Compliance Program

The Department of Justice (DOJ) updated its guidance to help prosecutors to evaluate corporate compliance programs.  Prosecutors rely on this guidance when evaluating business organizations during an investigation, determining whether to bring charges or when entering into a plea agreement. Is it applied effectively so that it mitigates risk identified during a risk assessment process?

PTSD, Veterans And Suicide: Action Is Needed, And Cannabis May Help

With both deaths occurring near hospitals servicing the Department of Veterans Affairs, the VA was very much in the spotlight, as the media and citizens tried to make sense of the far-too-common tragedy of veteran suicides. Veterans have a hard time getting access to the plant: the VA is a federal agency and therefore must follow federal laws.

Survey: Most Bankers In The US Want To Get Cannabis Clients—With Federal Protection

Fintech company Promontory Interfinancial Network recently conducted a survey of bankers in the U.S. Results showed that 82 percent of respondents think the federal government should allow them to serve ...

All Eyes on Aurora Cannabis (ACB) Stock Ahead of Earnings This Evening

Today after the market closes, Aurora Cannabis (ACB) is set to report FQ3 numbers for the March quarter. The numbers are crucial as they provide insight into the troubling sales of legalized cannabis in the Canadian adult-use market. With all data points suggesting weak legal sales, the company has a high hurdle to match analyst estimates for sequential revenue growth.Downside RiskAnalysts forecast Aurora to lose 50 cents per share on revenue of C$67.5 million. The company generated net revenues of C$54.2 million and net cannabis revenue of C$47.6 million in the December quarter and lost a substantial C$238 million due to investment losses.The risk here is to the downside with reported monthly sales in Canada remaining relatively flat. The only revenue growth is likely to come from recent acquisitions like Whistler Medical Marijuana Corp. that closed during the March quarter.A couple of key figures for the quarter are the gross margin and the average net selling price. In FQ1, Aurora saw the gross margin dip to 54% and the selling price for dried cannabis fell 26% sequentially to C$6.23 per gram. Any weakness here is problematic for the stock.The lack of organic growth would normally crush a pricy stock, but the stock market is likely to still latch onto high hopes for the global cannabis market.High Hopes The question Aurora needs to answer for investors is what happens with the additional supply hitting the market this quarter. The large cannabis company has long projected reaching an annual production rate of 150,000 kg by the end of March.Due to the time period for the cannabis supplies to reach the market, Aurora forecasts 25,000 kgs available for sale in the June quarter. The number is 3.5x the 6,999 kgs sold in the December quarter while demand is not growing due in large part to the illegal market.Along with the forecast for the higher production and sales level, management promoted the concept of Aurora being EBITDA positive in the June quarter. With the quarter halfway over, the risk is that management has to walk back this target due to lackluster sales and prices.Aurora raised their total projected capacity from 500K kg to 625K kg back in early April, which it expects to reach my mid calendar 2020. A big question remains the justification of increasing planned capacity by 25% without any sign that all of the existing cannabis capacity will be absorbed. Any failure to explain this corporate decision could weigh on the stock.Some potential upside comes from Ontario opening up additional retail stores after having an initial restriction of retail stores and the consumables market opening up in October. The addition of vapes, edibles and beverages will open up new revenue streams currently restricted, but the company has a lengthy period to transition to these new products.TakeawayThe key investor takeaway is that Aurora stock is in a precarious position where the company will have a difficult time maintaining previous lofty projections. With about 1.1 billion shares outstanding, the stock still has a market value of ~$9 billion despite the dip to multi-months lows at $8.The risk is to the downside, if management confirms some of the worst fears regarding pricing, mounting losses and wild capacity expansion. The likely outcome is that Aurora stock still spins a bullish market thesis due to global expansion and the further opening up of the domestic Canadian cannabis market. The market likely gives the stock a pass on weak results.To read more on the nitty gritty of what’s going on in the rising cannabis industry, click here. Read more on ACB: * Aurora Cannabis (ACB) Stock Is Still a Buy, Says Analyst * M&A to Save Aurora Cannabis (ACB) Stock in the End * The Cannabis ‘Magic Bus’ Is About to Leave the Station! Next Stops? Aurora Cannabis (ACB) More recent articles from Smarter Analyst: * Love or Hate Aurora Cannabis (ACB) Stock, That’s Where the Money Is * Micron's (MU) Tech Roadmap Highlights Flattening Cost Curve, Says Analyst; Reiterates Neutral on the Stock * Love or Hate Aurora Cannabis (ACB) Stock, That’s Where the Money Is * Time to Cash Out on Cannabis Stock Canopy Growth (CGC)

A Survivor's Story: Meet L.A. Weekly's New Cannabis Editor

I hear it, and I’m taken to a distant place and time. Snapshots of formative years play like a grainy old newsreel. Images powerful and iconic; sounds and smells palpably memorable. My personal time capsule ...

Please let us know of any additional Marijuana Stock Tickers you would like to see! We will update this page regularly to follow all the latest news in the Cannabis sector.